Martin Kleckner Picture v2
Senior Business Consultant
background comprises 26 years on senior level operations, general management, marketing and business development in the life sciences, oil & gas, cable television, counter-intelligence and aerospace.
current work encompasses guiding emerging and established companies with corporate planning and strategy, commercialization and business development, marketing, and public policy throughout Europe, Asia & the Americas.
He is a co-founder of RefluxMD.com, a Health 2.0 Internet company specializing in gastroesophageal reflux disease.
He further provides commercialization advisory support to the National Institutes of Health, Drexel Foundation, and Coulter Foundation with regard to awarded grants plus "Go/No-Go" grant funding decisions.
He was previously Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc., a 501 (c) 3 not-for-profit enterprise specializing in the translation and advancement of new molecular biology (genomics and proteomics) diagnostics and treatments via foundation and corporate life science partnerships.
Previously he was Chief Executive Officer for U P Laboratories in San Diego for the development of proprietary synthetic peptides (excitation secretion uncoupling peptides) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis.
Earlier he was Senior Vice President for Business Development at InSilicoMed, a start-up company providing bioengineering simulation tools for cardiology and ophthalmic therapy applications; Senior Vice President of Business Development and angel investor for RegeneMed, a company creating three dimensional (3D) engineered liver tissue for drug discovery and bio-artificial liver support; co-founder and Chief Business Officer for Salvino-Flex LLC wherein he managed the research and development of a chest tube insertion device, ultimately selling the company.
He was also Director of Development for Science and Engineering Associates for the commercialization of a diagnostic technology applicable to cervical, ovarian and oral/pharyngeal cancers.
He has further served as healthcare economist for Roche, Respironics, Toshiba Medical, and Terumo Interventional while also teaching courses for General Electric at its Crotonville, New York campus.
He was the co-founder/CEO of a counter-intelligence device which was showcased worldwide on BBC, NBC, CBS and Fox (receiving an 11-minute lead story) and then was used to help solve a crime in a May 2004 episode of 'CSI Miami'.
Previously he was Director of Venture Development/Contracts Executive with American Healthcare Systems serving in the starting group growing the company to $45 million in annual revenue eventually selling to Premier, Inc.
He was General Manager for Times Mirror with direct responsibility for its leading cable television performer (a $19 million division), and launched a nationwide initiative for cable system reorganization, mergers, swaps, and divestitures eventually leading to sale of the remaining company to Cox Communications.
Finally he was Corporate Planning Analyst for Berry Industries and California Shipbuilding specializing in mergers and acquisitions plus served as legislative advocate in the California state Senate and Assembly and Washington DC.
education consists of an MBA from the University of California, Los Angeles
(UCLA) Anderson School; a PhD in Public Policy from the University of California, Riverside; a certificate in public health from the University of California, San Diego
(UCSD); and a Bachelor of Arts (BA) with concentrations in public policy and economics from Whittier College